Discarded Targeted Oral Anticancer Medication-A Hard Pill to Swallow?
JAMA Oncol
.
2023 Sep 1;9(9):1202-1204.
doi: 10.1001/jamaoncol.2023.2226.
Authors
Cathy J Bradley
1
,
K Robin Yabroff
2
,
Ya-Chen Tina Shih
3
4
Affiliations
1
University of Colorado Comprehensive Cancer Center and Colorado School of Public Health, Aurora.
2
Surveillance and Health Equity Science Department, American Cancer Society, Atlanta, Georgia.
3
Section of Cancer Economics and Policy, Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston.
4
University of California-Los Angeles Jonsson Comprehensive Cancer Center and UCLA School of Medicine, Los Angeles.
PMID:
37471094
DOI:
10.1001/jamaoncol.2023.2226
No abstract available
Publication types
Research Support, N.I.H., Extramural
Editorial
Comment
MeSH terms
Administration, Oral
Humans
Medication Adherence*
Grants and funding
R01 CA225647/CA/NCI NIH HHS/United States